Navigation Links
Lesser Know Facts about Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic pulmonary fibrosis (IPF) is a disease whose cause and cure are not studied and there is also no known treatment for it till date//. It is a lung disease characterized by scarring in the lungs causing fibrosis and slow deterioration of the entire organ (lung).

Statistics show that approximately 83,000 Americans suffer from the disease and 31000 new cases are diagnosed every year. Ten years ago Jean Thompson became a prey to the disease and now her twin sister joy Thompson is suffering from this incurable lung disease. It is a very sad situation that till date there is no accepted treatment. New research is done by patient-centered non-profit organization called the Coalition for Pulmonary Fibrosis (CPF). This has done a lot to help patients suffering from IPF. Mark Shreve, CEO of the CPF said that when it affected the twin sisters they have not heard of the disease. This is because there were no resources available to conduct clinical trials for disease.

When Jean was suffering from the disease there was no correct diagnosis which brought her to the last stage of the disease. Hence CPF helped patients educate themselves about the disease. CPF was formed by a group of physicians, patients, family members and non-profit organizations who saw a huge unmet need. It has set various options of treatment for those suffering from IPF such as lung transplantation and pulmonary rehabilitation. CPF has added a network of 35 support groups and important patient access to physician referrals.

In 1999 the American Thoracic Society released a consensus statement regarding the diagnosis and treatment of the disease. It is thought that genetics may play a role in the causes of IPF for some patients. But the genetic link has not been pinpointed. several investigational therapies are in the pipeline such as interferon gamma 1-b, pirfenidone, imatinib mesylate, etanerrcept, and iloprost-listed alpha that may hold the key to life-saving treatments for the disease.
'"/>




Related medicine news :

1. UK Witnesses Lesser Number Of Flu Cases
2. Botox Treatment Now With A Lesser Dose And Increased Safety
3. Differently Wired and Gay – Are They Children of a Lesser God
4. Research Finds Lesser Rectal Cancer Risks Associated with Prostatic Irradiation
5. Lesser Health care associated infections in Irish Hospitals.
6. Lesser Calories for Longer Life
7. Developing Nations to Get Gardasil at Lesser Rates from Merck Soon
8. Lesser the Better- Minimally Invasive Surgery Breakthrough
9. Facts about Common Cold and Flu
10. Plane Facts: Beneficial To Have Medics Full-Time In Super Jets
11. The Little Known Facts of Junk DNA
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2016)... Angeles, CA (PRWEB) , ... February 10, 2016 ... ... Programming (NLP) practitioner, is known locally for a series of therapeutic sessions to ... in-the-moment in their characters and in their lives. The series, known as “Mindfulness ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... unveiling its revolutionary new 2.0 version at the International Roofing Expo in Orlando, ... power of the world's most advanced weather technology in the hands of consumers, ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... master charity program created to assist the local community. Pledging to select a ... and nonprofit organizations in the area. Their goal is to bring community awareness ...
(Date:2/10/2016)... ... ... Ongoing news of the ravages of traumatic brain injury (TBI) among former ... takes a closer look at cases of TBI being managed by their members. The ... the aging population, and identifies the challenges associated with their care. , During the ...
(Date:2/10/2016)... ... February 10, 2016 , ... Armune BioScience signed a ... network of laboratory service centers across the country. Launched in April of 2015, Apifiny ... detection of prostate cancer. Apifiny order volume exceeded 3,000 tests in 2015. Primary care ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... -- Mast Therapeutics, Inc. (NYSE MKT: MSTX), ... cell disease and heart failure, today announced the pricing ... a price to the public of $0.275 per unit. ... common stock and one warrant to purchase one share ... of $0.42 per share. The warrants are exercisable six ...
(Date:2/10/2016)... Feb. 10, 2016  Silicon Biosystems Menarini Inc., ... that help uncover the biological complexities of disease ... a developer of innovative technologies for genomics research, ... aimed at enabling translational researchers to obtain high-quality ... hundred tumor and normal cells in an optimized ...
(Date:2/10/2016)... Feb. 9, 2016 CTI BioPharma Corp. ... an update regarding the clinical studies being conducted ... for pacritinib. Following the issuance of the Company,s ... clinical hold issued by the U.S. Food and ... Company received an oral communication from the FDA ...
Breaking Medicine Technology: